Eight oral presentations and six posters demonstrate advances in mammography, DBT performance, and density-informed risk modeling

SEOUL, South Korea, Dec. 2, 2025 /PRNewswire/ — Lunit, a leading provider of AI for cancer diagnostics and precision oncology, today announced it will present 14 studies at the Radiological Society of North America (RSNA) 2025 Annual Meeting. Spanning screening mammography, digital breast tomosynthesis (DBT), breast density science, and risk modeling, this year’s program represents one of the company’s most extensive evidence portfolios to date. Lunit will exhibit at South Hall, Booth #4100, and host expert-led sessions in the Lunit Education Room #1252 throughout the meeting.

Among the highlighted research, real-world results from Capio S:t Göran Hospital in Sweden evaluated more than 193,000 screening examinations before and after the introduction of Lunit INSIGHT MMG. When AI was paired with a single radiologist, the screening program achieved higher invasive cancer detection, greater positive predictive value, and fewer unnecessary recalls compared to human-only double reading—reinforcing findings from the ScreenTrustCAD interventional trial and demonstrating that AI-integrated single reading can maintain or improve accuracy while alleviating workforce pressure.

New evidence from Massachusetts General Hospital assessed AI performance on screening DBT using 1,000 retrospective examinations, showing that Lunit INSIGHT DBT correctly localized 84.4% of true-positive cancers, with particularly strong performance for mass-presenting and invasive ductal carcinoma cases. The study also detailed cancer subtypes less likely to be identified by AI, offering practical insight into the algorithm’s strengths and limitations as DBT adoption accelerates worldwide.

Further expanding the evidence base, two oral presentations from Elizabeth Wende Breast Care explored how volumetric breast density, as quantified by AI-powered algorithms, and family history influence risk stratification across leading models, and how density changes over time affect prediction consistency. In a cohort of 44,651 women, Tyrer-Cuzick classified substantially more women as high-risk than BOADICEA, driven by heavier weighting of density and family history inputs. A complementary longitudinal analysis of 335,000+ images demonstrated that incorporating volumetric breast density over time improved calibration and discrimination, while static or categorical density inputs consistently underestimated cancer incidence. Together, these findings strengthen the role of density-informed and longitudinal risk modeling in supporting risk-adapted screening strategies.

Lunit will also host a series of expert-led sessions in its Education Room #1252, offering deeper clinical and scientific perspectives on key themes presented at RSNA. Highlights include:

• Image-Based Risk (Nov 30, 1:30–2:00 PM CST)

  A cross-disciplinary discussion featuring Drs. Graham Colditz, Joy Jiang, and Hari Trivedi, exploring how image-based risk complements traditional models and what this means for more personalized, risk-adapted screening strategies.

• Interval Cancer Detection with AI (Dec 1, 11:30 AM–12:00 PM CST)

  Prof. Fiona Gilbert (University of Cambridge) will present new evidence on the ability of AI to identify interval breast cancers typically missed during routine screening, outlining how AI-supported detection could reduce missed cancers and improve population-level screening outcomes.

• Academic Leadership in AI Adoption (Dec 2, 10:30–11:00 AM CST)

  Drs. Liz Morris (UC Davis Health) and Elizabeth Burnside (University of Wisconsin–Madison) will compare two distinct approaches to implementing breast AI in academic environments. The session will examine evidence, ethics, and practical considerations for responsible adoption.

• Real-World DBT Performance (Dec 2, 4:30–5:00 PM CST)

  Dr. Manisha Bahl (Mass General) will share new clinical data on how Lunit INSIGHT DBT performs in digital breast tomosynthesis workflows, highlighting improvements in cancer detection, diagnostic consistency, and the potential to reduce interval cancer rates when integrated into routine practice.

“RSNA is where the field looks to understand whether AI is delivering measurable clinical value, and this year’s program reflects that momentum,” said Brandon Suh, CEO of Lunit. “Across mammography, DBT, and density-driven risk modeling, our studies highlight how rigorously validated AI can enhance screening performance, support radiologists, and strengthen the foundation for risk-adapted care. We remain committed to generating evidence that drives responsible and meaningful adoption in clinical practice.”

###

About Lunit

Founded in 2013, Lunit (KRX: 328130) is a global leader on a mission to conquer cancer through AI. Our clinically validated solutions span medical imaging, breast health, and biomarker analysis—empowering earlier detection, smarter treatment decisions, and more precise outcomes across the cancer care continuum.

Lunit offers a comprehensive suite spanning risk prediction and early detection to precision oncology. Our FDA-cleared Lunit INSIGHT suite and breast health solutions support cancer screening in thousands of medical institutions worldwide, while the Lunit SCOPE platform is used in research partnership with global pharma and laboratory leaders for biomarker research, and companion diagnostic development.

Trusted by over 10,000 sites in more than 65 countries, Lunit combines deep medical expertise with continuously evolving datasets to deliver measurable impact—for patients, clinicians, and researchers alike. Headquartered in Seoul with global offices, Lunit is driving the worldwide fight against cancer. Learn more at lunit.io/en.

Appendix – Lunit RSNA 2025 Full Study List

Oral Presentations (8)

• #1 T3-SSBR05, COMPARING FOUR COMMERCIAL AI ALGORITHMS FOR STANDALONE BREAST CANCER DETECTION ON DIGITAL BREAST TOMOSYNTHESIS IN A DUTCH POPULATION-BASED SCREENING COHORT—Sarah D. Verboom, MSc, Radboud university medical center
• #2 T3-SSBR05, MAMMOGRAPHY BREAST CANCER SCREENING TRIAGE USING DEEP LEARNING: RETROSPECTIVE COMPARISON OF 7 COMMERCIAL AI ALGORITHMS—Joshua Rothwell, University of Cambridge
• #3 W2-SPBR, EXPLORING HOW AI INFLUENCES HUMAN DECISION MAKING AND GAZE BEHAVIOUR DURING MAMMOGRAPHY INTERPRETATION—Yan Chen, PhD, Nottingham University
• #4 W3-SSER02, COMPARISON OF THE ACCURACY OF ARTIFICIAL INTELLIGENCE SOFTWARE FOR THE DETECTION OF PNEUMOTHORAX ON CHEST RADIOGRAPHS—Katrina Nash, MBChB, Oxford University Hospital
• #5 M7-SSBR04, EVOLUTION OF BREAST CANCER SCREENING: FROM HUMAN-ONLY DOUBLE READING VIA AI-INTEGRATED DOUBLE READING TO AI-INTEGRATED SINGLE READING—Karin Dembrower, MD, PhD, Karolinska Institute
• #6 S5-SSBR02, COMPARING HIGH RISK ESTIMATIONS USING VOLUMETRIC BREAST DENSITY WITH TYRER-CUZICK AND BOADICEA RISK MODELS—Stamatia V. Destounis, MD, Elizabeth Wende Breast Care
• #7 M7-SSBR03, IMPACT OF BREAST DENSITY CHANGE OVER TIME ON RISK MODEL CALIBRATION AND PREDICTION ACCURACY—Stamatia V. Destounis, MD, Elizabeth Wende Breast Care
• #8 M7-SSBR04, COMPARISON OF BREAST DENSITY AND AJCC BREAST CANCER PATHOLOGICAL PROGNOSTIC STAGE IN SCREEN DETECTED AND INTERVAL CANCERS IN A UK PROGRAMME—Fleur Kilburn-Toppin, MBBChir, MA, University of Cambridge

Poster Presentations (6)

• #1 R5B-SPBR, OPTIMIZING AI POSITIVE FINDINGS ON PRIOR NEGATIVE MAMMOGRAMS FOR CONTRALATERAL BREAST CANCER DETECTION AFTER BREAST CANCER SURGERY: DISTINGUISHING TRUE FROM FALSE POSITIVES—Eun Kyung Park, MD, PhD, Seoul National University
• #2 S3A-SPBR, WHAT AI SEES – AND WHAT IT DOESN’T: EVALUATING THE DETECTION OF BREAST CANCER SUBTYPES ON SCREENING DIGITAL BREAST TOMOSYNTHESIS—Manisha Bahl, MD, MPH, Massachusetts General Hospital
• #3 M5A-SPBR, A BIOPHYSICS-BASED COMPUTATIONAL APPROACH BOTH OUTPERFORMS AND SYNERGIZES WITH A COMMERCIAL MAMMOGRAPHIC DENSITY ASSESSMENT SOFTWARE FOR BREAST CANCER PREDICTION—Andre Khalil, PhD, MS, University of Maine
• #4 M5A-SPBR, ARTIFICIAL INTELLIGENCE-DERIVED MAMMOGRAPHY SCORES CAN PREDICT ONCOTYPE DX RISK SCORES IN ESTROGEN RECEPTOR POSITIVE BREAST CANCERS—Jung-Oh Lee, MD, MSc, Seoul National University
• #5 T5A-SPBR, AI-BASED MAMMOGRAPHY SCORES FOR PREDICTING PATHOLOGIC AXILLARY METASTASIS AFTER NEOADJUVANT CHEMOTHERAPY IN BREAST CANCER PATIENTS—Na Lae Eun, MD, PhD, Severance Hospital
• #6 T5A-SPBR, ARTIFICIAL INTELLIGENCE (AI)-BASED MAMMOGRAPHY SCORES FOR PREDICTING PATHOLOGIC COMPLETE RESPONSE IN BREAST CANCER PATIENTS RECEIVING NEOADJUVANT CHEMOTHERAPY—Na Lae Eun, MD, PhD, Severance Hospital

New solution harnesses Solace’s market-leading real-time data platform to enable enterprises to build and orchestrate robust and reliable single and multi-agent AI applications

LAS VEGAS, Dec. 2, 2025 /PRNewswire/ — AWS re:Invent 2025, Booth # 1570 — Solace, the real-time data and agentic AI company, today announced general availability (GA) of Solace Agent Mesh Enterprise, an open agentic AI platform that enables organizations to build, deploy and operate intelligent and well-governed AI-powered applications – from simple single-agent to powerful multi-agent orchestrated solutions – that interact in real-time with enterprise applications and data.

Agentic AI promises greater productivity and increased competitiveness, with a recent industry report indicating it can accelerate business processes by up to 50 percent and reduce low-value work time by up to 40 percent, thanks to autonomous decision-making and continuous learning capabilities. Getting there remains a challenge, however, as organizations struggle to move agentic AI applications from experiments into production, providing access to enterprise applications and data while ensuring security, observability, and trust.

Additionally, IDC states: “Agentic AI will require event-driven data architectures to continuously provide high-quality, relevant, and contextual data products to support the dynamic nature of agentic business activities. Supporting agentic AI at scale demands use of autonomous agents within enterprise intelligence architectures, automating data management, governance, and synthesis functions.” *

Solace Agent Mesh addresses these challenges, providing the capabilities required to create, deploy and manage agentic AI solutions in a secure, governed and scalable way. Built on a proven event-driven platform, Solace Agent Mesh fundamentally transforms how agentic AI systems serve users, respond to business events and integrate with enterprise data, offering:

• Faster time to innovation: enterprises can rapidly innovate by integrating and orchestrating native and third-party AI agents, enabling faster experimentation, accelerated development, and quicker time-to-market
• Improved user experience: business users can talk with their data using their preferred user interfaces, with broad access to enterprise applications and data, whether real-time or static knowledge bases
• Greater scalability and reliability: Solace Agent Mesh uses parallel agent execution and asynchronous communication between all agents, enabling horizontal scaling to production levels while also providing a stronger level of resilience in response to system failures and implementing hot agent upgrades
• Increased operational efficiency: Solace Agent Mesh’s unique intelligent data management helps minimize LLM costs, while significantly improving performance and accuracy
• Comprehensive security: strong agent-based access control, SSO, action-level permissions, and user delegated access deliver the critical security, governance and compliance required for AI agent-driven solutions

“There are many challenges to overcome in relation to enabling AI agents to take automated actions and there is a case to be made for involving experts in inter-application communication,” said Matt Aslett, Director of Research, Analytics and Data, ISG Research. “Solace is well-placed to address this opportunity with Solace Agent Mesh, which provides the core capabilities required for communication between agents and will enable Solace customers and prospects to build on existing investments in microservices and EDA as they move towards agentic AI.”

The Forrester Wave™: Streaming Data Platforms, Q4 2025 notes: “Solace’s event-driven agents stand out: they help enterprises build responsive, real-time, event-driven applications and enable high-performance streaming for enterprise applications.” **

Secure, Scalable and Enterprise-grade functionality

Solace Agent Mesh was built from the ground up as an open, flexible platform designed to make it easy for enterprises to experiment with single or multi-agent systems to deliver on their agentic AI objectives, from simple uses cases to the most demanding distributed organization-wide production deployments.

Key features include:

• No-code Agent Builder: both pro-code agent building, as well as an AI-assisted, form-based interface for creating agents without writing code
• Dynamic Agent Orchestration: Solace Agent Mesh uses an intelligent orchestrator to break down inputs into tasks and assign them to the right agents in real time. It can also follow prescriptive workflows when it is critical to operate in specific ways
• Connectors: out-of-the-box SQL, API, and MCP connectors provide simple and broad connectivity to enterprise applications and data, both real-time and static knowledge bases
• Gateways: business users can use their preferred tools such as web chat, Slack or Microsoft Teams to interact with Agent Mesh, as well as set up Agentic Process Automation workflows invoked through events, enterprise application APIs and Webhook
• Governance and Access Control: gateways serve as controlled entry points into the framework, granting access to the agent ecosystem through different interfaces like events, APIs, web chat, Slack, and Microsoft Teams. Solace Agent Mesh offers single sign-on authentication as well as granular authorization and role-based access control, ensuring agents interact with applications and data with the permissions of the requesting user
• Intelligent Data Management: innovative intelligent data management helps reduce LLM compute costs and avoids hallucinations through in-platform data operations and passing only relevant information to the LLM
• Full Activity Observability: built-in workflow viewer and real-time observability tools enable comprehensive monitoring and tracking of LLM interactions, agent workflows, and system performance to build system trust and help debug
• Enterprise-scale Architecture: decoupled, asynchronous orchestration of agents supports efficient parallelization of operations, enabling agentic AI projects to easily scale from Proof-of-Concept to production

“Agentic AI has completely changed the face of business, and requires revolutionary solutions to continue to fuel its unprecedented growth. Solace Agent Mesh Enterprise is the net result of a bold vision on how organizations can better harness the power of agentic AI,” said Shawn McAllister, CPO and CTO at Solace. “Organizations can quickly go from experiments to full scale enterprise production with fast development, and secure access to enterprise context, all powered with the proven robustness of an event driven architecture. Agent Mesh is designed to meet the ever-evolving needs of increasingly connected, real-time, and intelligent enterprises.”

Prospective organizations can register to join the Solace Agent Mesh pilot program. In addition to Solace Agent Mesh Enterprise, Solace offers open-source Solace Agent Mesh Community available on GitHub, providing developers with an event-driven framework for seamlessly integrating AI agents with real-world data sources and systems. 

Learn more

• Connect with Solace for a personal demo at AWS re:Invent, Booth 1570, December 2-5, 2025
• Read our blog on the Solace Agent Mesh Enterprise launch
• Read our key takeaways on Gartner’s August 2025 report, Innovation Insight: AI Agent Development Frameworks, which lists Solace as one of eight representative vendors

Market Leadership

Over the past two decades, Solace has built a reputation for delivering real-time data solutions that are trusted by enterprises with the most demanding operational use cases. Today, Solace delivers real-time data orchestration across systems, clouds and AI agents for many of the top organizations spanning key industries, such as Bosch in manufacturing; Heineken in consumer goods; Schwarz Group in retail; RBC Capital Markets in financial services; and PSA Singapore in transportation & logistics.

* IDC Tech Buyer, Agentic AI Impact on Enterprises: From the Tech Stack to the Future of Work and Services, US53272524, April 2025
** Forrester does not endorse any company, product, brand, or service included in its research publications and does not advise any person to select the products or services of any company or brand based on the ratings included in such publications. Information is based on the best available resources. Opinions reflect judgment at the time and are subject to change. Read about Forrester’s objectivity here.

About Solace:

Solace helps organizations operate in real-time through the power of events. With its real-time data and agentic AI platform, Solace delivers scalable, event-driven capabilities to bring together agents, applications and data across legacy, cloud, and AI systems. Established enterprises worldwide trust Solace to enable intelligent, time-sensitive experiences; modernize their application and integration landscape; and create seamless digital journeys for their customers, partners and employees. Learn more at solace.com.

Press Contacts

Europe & Americas
IBA International
Jamie Kightley
Jkightley@iba-international.com
+44 (0) 1572 757932

UK
Positive
Calum Mitchell
cmitchell@positivemarketing.com
+44 7793 160127

APAC
Rice, a FINN Partners Company
Trixie Wong
trixie.wong@finnpartners.com
+65 9757 7531

The upsized working capital credit facility was increased to $75MM in the U.S. and an additional $5MM for Next Level Aviation-Ireland, Ltd.

DANIA BEACH, Fla. and DUBLIN, Dec. 2, 2025 /PRNewswire/ — Next Level Aviation^® (NLA), a leader in the global distribution of used serviceable materials (USM) for all Boeing and Airbus commercial aircraft and associated jet engine platforms, has secured an increase in its revolving credit facility with PNC Bank for the U.S. based parent company from $50MM to $75MM, as well as an additional $5MM credit facility for Irish subsidiary, Next Level Aviation-Ireland, Ltd (NLAI). Both credit facilities have the potential to expand over time as NLA and NLAI grow.

This significantly upsized working capital credit facility will allow Next Level Aviation^® to increase inventory of serviceable material, continue to expand its geographic footprint, as well as support NLA’s diversification into other complementary lines of business.

Next Level Aviation^® Chairman & CEO Jack Gordon stated, “We are very appreciative that PNC Bank, one of the largest diversified financial institutions in the United States, has the confidence in Next Level Aviation’s global business model, management team and financial performance to increase our total access to asset-based credit by 60% in less than one year of working together, in addition to extending our Irish subsidiary, Next Level Aviation-Ireland, Ltd., its first revolving credit facility. We would like to again thank the PNC Business Credit team for their commerciality and client-focused, solutions-based approach to our partnership.”

Ray Fernandez-Andes, Next Level’s Chief Financial Officer, commented, “As we continue to grow, the global nature of Next Level Aviation’s business presents both unique challenges and opportunities. The PNC Business Credit team has taken the time to understand all of this, and crafted banking solutions that set Next Level Aviation^® up for continued success in the commercial aviation aftermarket.”

ABOUT NEXT LEVEL AVIATION^®
Next Level Aviation^® is an ASA-100 accredited and FAA Advisory Circular 00-56B compliant supplier stocking commercial aircraft/jet engine used serviceable material (USM) for all Boeing and Airbus aircraft platforms and associated jet engines. Next Level Aviation^® specifically focuses on stocking USM for the Boeing 737 and Airbus A320 families of aircraft and their associated jet engines, which currently make up about 70% of the global commercial fleet. Founded in March 2013 by Jack Gordon, Mike Dreyer, and Matt Dreyer, Next Level Aviation^® has grown into a top global supplier of commercial aircraft/jet engine used serviceable material. www.nextlevelaviation.net

To find out more information or to request additional images, please contact morgane@aerospacemarketing.com.

• Expert in sales and commercial strategy…Ex-Philips and previously served as Chief Commercial Officer (CCO) at Cortechs.ai
• To strengthen revenue growth of AI-based brain imaging solutions in the North American market and expand product deployment across healthcare institutions

SEOUL, South Korea, Dec. 2, 2025 /PRNewswire/ — Neurophet (Co-CEOs Jake Junkil Been and Donghyeon Kim), an artificial intelligence (AI) solution company for brain disorders diagnosis and treatment, announced on 2nd that it has appointed Josh Cohen, a veteran executive from leading global medical device companies, as new Head of Americas Business.

Josh Cohen, newly appointed Head of Americas, brings over a decade of expertise in sales and commercialization strategy within the medical AI sector. He has honed his skills through leadership roles in global sales and marketing at top-tier medical device companies, including Philips—one of the world’s leading medical imaging manufacturers—as well as Cortechs.ai, Shared Imaging, and most recently has worked as the acting Chief Commercial Officer (CCO) with MRI AI-based technology companies to launch and scale in the US and abroad.

Josh Cohen previously served as CCO at Cortechs.ai, one of Neurophet’s global rivals, where he spearheaded the growth of key AI-driven brain imaging analysis products and led the company’s expansion across international markets. Cortechs.ai specializes in AI-based medical imaging analysis software and directly competes with Neurophet in the Americas region.

Neurophet, market leader in the Asia Pacific region, is now focused on accelerating its entry into the Americas with this key appointment. Having led the execution of global commercialization strategies at a leading AI brain imaging analysis company, Josh Cohen will now build the team, the operations, and the customer success for Neurophet in the Americas.

With patients, clinicians, and customer satisfaction at the forefront, Neurophet aims to drive revenue growth, establish distribution partnerships, and implement market entry strategies across Canada, the United States, and South America.

Josh Cohen, Head of Americas Business at Neurophet, stated “I am delighted to be part of Neurophet, a company with global competitiveness in the field of imaging analysis related to Alzheimer’s disease treatment prescriptions and look forward to accelerating product sales by strengthening our entry into the North American market.”

Jake Junkil Been, Co-CEO of Neurophet, said “With Josh Cohen joining us, the pivotal leader behind the rapid growth of our key competitor Cortechs.ai, Neurophet is well-positioned to accelerate product deployment throughout the North American market. Looking ahead, we aim to expand our product offerings with a strong focus on major healthcare institutions across the United States.”

About Neurophet

Neurophet specializes in developing solutions for diagnosis support, treatment guides, and treatment devices targeting brain disorders based on cutting-edge artificial intelligence (AI) technology. The company was founded in 2016 by Co-CEOs Jake Junkil Been and Donghyeon Kim, who developed the next-generation neuro-navigation system.

Major products include brain MRI analysis software “Neurophet AQUA”, PET Image Quantitative Analysis Software “Neurophet SCALE PET”, Brain imaging treatment planning software for electric and magnetic brain stimulation “Neurophet tES/TMS LAB”, Alzheimer’s Disease treatment prescription and monitoring software “Neurophet AQUA AD” for tracking treatment efficacy and side effects, and Multiple Sclerosis image analysis software “Neurophet AQUA MS”.

Neurophet has set its top priority to helping patients suffering from brain disorders. Based on expertise in neuroscience, Neurophet will continue to challenge and grow to explore the human brain’s health and pioneer solutions for brain diseases with AI technology.

• The new milestone came only 13 months after the opening of the 600th store
• Paris Baguette is aggressively expanding its franchise footprint in Europe, building on its success in the US and China
• The multi-unit franchise operation demonstrates the brand’s competitiveness and franchise partnership
• Paris Baguette is scheduled to open its third franchise location near Portobello Market at end-2025

SEOUL, South Korea, Dec. 2, 2025 /PRNewswire/ — Paris Baguette, the global bakery-café franchise under the SPC Group, is adding a new location in Westfield, expanding its global store count to 700. The new milestone came only 13 months after the company celebrated the opening of its 600^th store in mid-October 2024.

Paris Baguette Westfield is Paris Baguette’s fourth location and second franchise store in the UK, reflecting the company’s success in expanding its franchise footprint beyond the US and China to Europe. Paris Baguette’s first franchise store in Canary Wharf has experienced a steady inflow of customers since the opening in November 2024, establishing a compelling presence in the UK market. Paris Baguette Canary Wharf is now well positioned to thrive, aided by a high repeat purchase rate. Notably, the Westfield location is opened by the owner of the first Paris Baguette franchise store. The multi-unit franchise operation demonstrates Paris Baguette’s solid brand competitiveness and franchise partnership.

The Westfield store is located on the ground floor of Westfield London, a large shopping mall in the Shepherds Bush area of west London. With hundreds of global brands across luxury goods, fashion, lifestyle and home appliance categories, Westfield London is one of the biggest shopping centers in the UK, attracting 50 million visitors annually. Paris Baguette Westfield features marble countertops, metal frames in the brand’s signature blue color, and wood finish, with the modern look accentuating the refined brand image. The Westfield store serves a diverse range of products including sandwiches, pastries, and cakes that have been well received by the UK and other European markets, creating unique experiences for both local customers and international visitors.

Wayne Stevenson, the owner of Paris Baguette’s first two franchise stores in the UK, said, “I am excited to be opening in a second location, as my first Paris Baguette in Canary Wharf has made its mark in the local community since its opening last year. What I have learned is that Paris Baguette leads the field in quality and innovation. I look forward to seeing Paris Baguette becoming a household name here.”

Paris Baguette launched in the UK in 2022, with a back-to-back opening of two sites in Battersea Power Station and Kensington High Street. In mid-December this year, the bakery-café chain is scheduled to open its fifth location and third franchise store in the UK, near Portobello Market, the setting for the movie Notting Hill, kicking its franchise business into high gear.

A Paris Baguette spokesperson said, “Building on the success of the first franchise store in the UK, we are adding two more franchise stores here. We are committed to enhancing brand awareness and competitiveness in Europe, where bread is a staple food, to take the lead in shaping the global bakery market.”

Paris Baguette made its initial foray into the global market in 2004 and has opened 700 stores in 15 countries over the past two decades across the US, Canada, France, the UK, Singapore, Vietnam, Indonesia, Malaysia, the Philippines, Cambodia, Thailand, Laos, Brunei, and Mongolia.